About
Specialties
- Price range
- Kč 27–Kč 4,300
- Treatments
- 15
- Locations
- 1
- Languages
- 1
Treatments
15 treatments
blood-testing
Liver & Kidney Function Panel
A combined liver and kidney function panel at MEDILA measuring renal clearance markers (creatinine, urea, uric acid), key electrolytes (sodium, potassium, chlorides, calcium, phosphorus), and urinalysis with sediment. Together these markers assess kidney filtration capacity, electrolyte balance, and urinary tract health in a single morning draw. Creatinine is the primary kidney biomarker for estimating GFR (glomerular filtration rate); urea reflects protein metabolism and kidney excretion; uric acid is the gout marker and an independent cardiovascular risk factor. The electrolyte panel adds cardiac and neuromuscular stability markers. Urinalysis with sediment detects protein, glucose, blood, and cellular casts in the urine — providing early warning signs of kidney inflammation, infection, and diabetic nephropathy. Written physician commentary included. Results within one week.
blood-testing
Liver Function Tests
A five-marker liver function panel at MEDILA measuring ALT, AST, ALP, GGT, and total bilirubin — the standard clinical suite for assessing hepatocellular injury, cholestasis, and bilirubin metabolism. Each enzyme has a distinct profile of elevation that helps localise the type of liver or biliary dysfunction: ALT and AST are the primary hepatocellular injury markers, elevated in hepatitis, fatty liver, and drug toxicity; ALP and GGT together indicate biliary and cholestatic disease; bilirubin reflects liver conjugation capacity and red cell turnover. This panel is appropriate for anyone monitoring liver health in the context of alcohol use, medication effects, metabolic syndrome, or fatty liver disease, as well as for people who notice jaundice or fatigue. Written physician commentary is included. Fasting of approximately 10 hours recommended; morning collection at any MEDILA collection centre without a physician referral.
blood-testing
Metabolic & Diabetes Panel
A core metabolic biochemistry panel at MEDILA covering glucose, HbA1c, creatinine, urea, and ALT — the foundational metabolic markers used to screen for and monitor diabetes, kidney function, and early liver disease in a single fasting blood draw. Glucose provides the acute blood sugar level; HbA1c reflects the 3-month average, the definitive diabetes screening and monitoring marker. Creatinine and urea assess kidney filtration capacity and excretory function. ALT is the primary liver health marker, elevated early in fatty liver, hepatitis, and hepatotoxic medication use. These five markers together form the minimal baseline biochemistry screen recommended in Czech preventive medicine guidelines for adults over 40. No appointment required at MEDILA collection centres. Fasting of 8–12 hours required for glucose and HbA1c.
blood-testing
Cardiovascular Prevention Panel
A focused cardiovascular prevention blood panel at MEDILA measuring 10 cardiac and metabolic risk markers in a single fasting draw. The panel covers acute cardiac injury (Troponin I), heart failure stress (NT-proBNP), thrombotic activity (D-dimers), primary cardiovascular risk (total cholesterol, LDL), cardiac muscle enzymes (CK, LDH), diabetes monitoring (HbA1c), fasting glucose, and the cardiac stability electrolyte (potassium). This combination is specifically designed to give a multi-angle view of cardiovascular health — identifying both long-term risk factors (elevated LDL, HbA1c, glucose) and acute indicators of cardiac stress (Troponin I, NT-proBNP) in a single panel. Written physician commentary included. Fasting of 8–12 hours required. Results within one week.
blood-testing
Tick-Borne Encephalitis (TBE) Antibody Test
A tick-borne encephalitis (TBE) antibody test at MEDILA measuring serum TBE IgG antibody levels to confirm the degree of immune protection following TBE vaccination. The Czech Republic has one of the highest rates of TBE in Europe — the virus is carried by Ixodes ricinus ticks common in forests and meadows throughout the country, and is the most significant tick-borne viral disease in Central Europe after Lyme disease. TBE vaccination is recommended for residents and travellers with outdoor exposure in endemic areas, but vaccine-induced immunity wanes over time and varies between individuals. This test is recommended 3–5 years after vaccination to determine whether a booster dose is needed, using the IgG titre to assess current protection levels. Written physician commentary explaining the result is included. No fasting required. Morning collection at any MEDILA collection centre.
blood-testing
Immunity & Autoimmune Panel
A targeted immune system and autoimmune status panel at MEDILA covering 12 biomarkers that collectively assess innate immune function, adaptive immunity, autoimmune thyroid activity, and nutritional immune support. The panel measures immunoglobulin classes (IgG, IgA, IgM), total IgE (allergy burden), zinc (micronutrient essential for immune function), Anti-TG and Anti-TPO (thyroid autoimmune antibodies), rheumatoid factor (RF), ASLO (anti-streptolysin O — streptococcal antibody), ESR, total hydroxyvitamin D, full blood count (CBC), and protein electrophoresis (ELFO). This is the appropriate panel for patients with recurring infections, suspected autoimmune thyroid disease (Hashimoto's), suspected rheumatoid disease, or those wanting a comprehensive view of their immune status. Physician commentary is included with results.
full-body-checkup
Kardio+ Advanced Cardiovascular Screening – Men
An extended men's health screening panel adding acute cardiac injury and heart failure markers to MEDILA's comprehensive baseline. Beyond the 30+ biomarkers in the standard men's panel, Kardio+ adds Troponin I (myocardial injury), NT-proBNP (heart failure stress marker), D-dimers (thrombosis/clotting), creatine kinase (CK), lactate dehydrogenase (LDH), Free T4 (extended thyroid), Free PSA (prostate differentiation), and a full electrolyte panel (sodium, potassium, chlorides, calcium, magnesium). This is the appropriate choice for men with cardiovascular risk factors, known cardiac symptoms, hypertension, or a family history of heart disease who want a clinically comprehensive cardiac risk screen rather than a basic lipid panel. Physician commentary and a doctor phone consultation within 14 days are included.
blood-testing
Vitamin D Status Panel
A focused vitamin D status test measuring total hydroxyvitamin D alongside calcium and inorganic phosphorus at MEDILA's ISO-accredited laboratory. Known in the Moje MEDILA catalogue as the "Hormon mládí" (Youth Hormone) panel, it reflects the widespread understanding that vitamin D functions as a hormone — regulating calcium metabolism, immune function, musculoskeletal health, mood, and metabolic processes across the body. Vitamin D insufficiency affects a significant proportion of the Central European population, particularly in the autumn and winter months when UV-B exposure is minimal. The calcium and phosphorus measurements contextualise the vitamin D result by assessing the downstream bone mineral balance markers that vitamin D regulates. Written physician commentary is included with results, delivered within one week. Preparation: fast approximately 10 hours, morning collection.
full-body-checkup
Comprehensive Prevention Screening – Women
MEDILA's comprehensive preventive screening for women covers 30+ biomarkers in a single fasting appointment, tailored specifically for women's health with CA 125 (ovarian cancer marker) replacing PSA. The panel covers the full blood count, lipid profile, liver and kidney function, thyroid (TSH), glucose, HbA1c, vitamin D, CRP, ferritin, protein electrophoresis, CEA, and urinalysis with sediment plus stool occult blood. Blood pressure measurement and physician commentary are included, with a phone consultation with a doctor within 14 days. This is the most complete annual self-pay blood panel offered through the Moje MEDILA portal for women seeking evidence-based preventive diagnostics in the Czech Republic. MEDILA holds ČSN EN ISO 15189 accreditation from the Czech Accreditation Institute.
full-body-checkup
Kardio+ Advanced Cardiovascular Screening – Women
MEDILA's extended women's health screening panel augments the comprehensive baseline with advanced cardiac injury and coagulation markers. Beyond the 30+ biomarkers in the standard women's panel, Kardio+ adds Troponin I, NT-proBNP, D-dimers, fibrinogen, creatine kinase (CK), lactate dehydrogenase (LDH), Free T4, and a full electrolyte panel (sodium, potassium, chlorides, magnesium). The inclusion of fibrinogen — the primary coagulation protein and an independent cardiovascular risk marker — is a distinctive feature of this panel not commonly found in standard preventive screens. CA 125 ovarian marker is retained from the base women's panel. Physician commentary and a doctor phone consultation within 14 days are included.
blood-testing
Thyroid Hormone Panel
Thyroid hormone testing at MEDILA starting with TSH (thyroid-stimulating hormone) — the single most sensitive marker for thyroid dysfunction and the international standard first-line thyroid screen. TSH rises in hypothyroidism and falls in hyperthyroidism, providing early detection before overt symptoms develop. Free T4 (the main circulating thyroid hormone) and Free T3 (the active form) can be added to complete the functional assessment. Autoimmune thyroid markers — Anti-TPO and Anti-TG for Hashimoto's thyroiditis, TRAK for Graves' disease — are individually orderable for patients with suspected autoimmune thyroid disease. No fasting is required for any thyroid marker. MEDILA holds ČSN EN ISO 15189 accreditation from the Czech Accreditation Institute. Results returned within one week.
blood-testing
Lipid Profile (Cholesterol & Cardiovascular Risk)
A fasting cholesterol and lipid panel at MEDILA measuring the four core cardiovascular risk markers: total cholesterol, HDL-cholesterol (protective), LDL-cholesterol (primary atherogenic marker), and triglycerides. This panel is the standard lipid screen used to assess cardiovascular risk in adults and to guide decisions about lifestyle changes and lipid-lowering therapy. LDL elevation is the primary target for cardiovascular risk reduction — European guidelines recommend LDL below 1.8 mmol/L for very high risk patients and below 2.6 mmol/L for high risk. HDL below 1.0 mmol/L in men and 1.2 mmol/L in women indicates reduced protective function. Triglycerides above 1.7 mmol/L signal metabolic syndrome risk. MEDILA's ISO 15189-accredited laboratories process fasting lipid panels with results returned within one week.
full-body-checkup
Comprehensive Prevention Screening – Men
MEDILA's flagship men's preventive blood screening covers 30+ biomarkers across all major health categories in a single fasting appointment. The panel combines a full blood count, lipid profile, liver and kidney function, thyroid (TSH), blood glucose, HbA1c, prostate marker (PSA), cancer markers (CEA), vitamin D, CRP, iron markers (ferritin), and protein electrophoresis — plus urinalysis with sediment and a stool occult blood test. Blood pressure measurement is also included. Physician commentary is written by a MEDILA doctor and delivered with results; a phone consultation with the doctor is included within 14 days of collection, making this a genuinely supported health assessment rather than a raw data dump. Fasting of 8–12 hours is required. Results are returned within one week via encrypted email or in-person pickup. MEDILA holds ČSN EN ISO 15189 accreditation from the Czech Accreditation Institute.
blood-testing
Full Blood Count (CBC) with Differential
A full blood count (CBC) with white cell differential at MEDILA's ČSN EN ISO 15189-accredited laboratory. The CBC is the foundational haematology test measuring red blood cell count, haemoglobin, haematocrit, MCV/MCH/MCHC indices, platelet count, and total white cell count. The 5-part differential classifies white cells into neutrophils, lymphocytes, monocytes, eosinophils, and basophils, providing a comprehensive picture of immune cell distribution. Together these measurements identify anaemia by type (iron deficiency, B12/folate, haemolytic), infection burden, inflammatory activation, and haematological conditions. No fasting is required. Walk-in collection is available Monday to Friday at MEDILA collection centres, with results typically available the same or next working day.
blood-testing
Gout Screening Panel
A targeted gout and uric acid screening panel at MEDILA measuring serum uric acid, CRP (C-reactive protein), and urinalysis with sediment. Elevated uric acid (hyperuricaemia) is the biochemical precondition for gout — the painful inflammatory arthritis caused by monosodium urate crystal deposition in joints, most commonly the big toe, ankle, and knee. CRP confirms whether active inflammatory arthritis is present alongside the hyperuricaemia, distinguishing gout from asymptomatic hyperuricaemia. Urinalysis detects urate crystals in urine and screens for kidney complications (uric acid kidney stones), which affect approximately 15–20% of patients with gout. The panel is appropriate for first-time gout diagnosis, monitoring in patients on urate-lowering therapy, and screening in men over 40 with a high-purine diet, alcohol consumption, or metabolic syndrome. Written physician commentary is included.
Locations
1 location